SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Variation in patient utilities for outcomes of the management of chronic stable angina. Implications for clinical practice guidelines. Ischemic Heart Disease Patient Outcomes Research Team
0 references·16 citing·48 second hop
Variation in patient utilities for outcomes of the management of chronic stable angina. Implications for clinical practice guidelines. Ischemic Heart Disease Patient Outcomes Research Team (1995)Variation in patient utilities for outcom…Economic Evaluation of a Pharmaceutical Care Program for Elderly Diabetic and Hypertensive Patients in Primary Health Care: A 36-Month Randomized Controlled Clinical Trial (2015)Economic Evaluation of a Phar…A Health Policy Model of CKD: 2. The Cost-Effectiveness of Microalbuminuria Screening (2010)A Health Policy Model of CKD:…Screening for Type 2 Diabetes Mellitus: A Cost-Effectiveness Analysis (2004)Screening for Type 2 Diabetes…The cost effectiveness of rofecoxib and celecoxib in patients with osteoarthritis or rheumatoid arthritis (2003)The cost effectiveness of rof…Patient and Community Preferences for Outcomes in Prostate Cancer (2003)Patient and Community Prefere…Utilities Measured by Rating Scale, Time Trade-off, and Standard Gamble: Review and Reference for Health Care Professionals. (2002)Utilities Measured by Rating …Assessing Values for Health: Numeracy Matters (2001)Assessing Values for Health: …Valuing Health-Related Quality of Life (2000)Valuing Health-Related Qualit…Parents' utilities for outcomes of occult bacteremia. (2000)Parents' utilities for outcom…A Review of the Use of Health Status Measures in Economic Evaluation (1999)A Review of the Use of Health…Patient-assigned health state utilities for depression-related outcomes: differences by depression severity and antidepressant medications (1998)Patient-assigned health state…Alternative approaches to valuing intangible health losses: the evidence for multiple sclerosis (1998)Alternative approaches to val…EUR-ASSESS Project Subgroup Report on Dissemination and Impact (1997)EUR-ASSESS Project Subgroup R…Convergent and Discriminant Validity of a Generic and a Disease-Specific Instrument to Measure Quality of Life in Patients with Skin Disease (1997)Convergent and Discriminant V…An evaluation of utility measurement in Crohn's disease (1997)An evaluation of utility meas…Health status and hypertension: A population-based study (1996)Health status and hypertensio…EuroQol - a new facility for the measurement of health-related quality of life (1990)An empirical comparison of EQ‐5D and SF‐6D in liver transplant patients (2003)SF-36 health survey: Manual and interpretation guide (2003)Valuing health care using willingness to pay: a comparison of the payment card and dichotomous choice methods (2003)Methods for the Economic Evaluation of Health Care Programmes (2005)Methods for exploring and eliciting patient preferences in the medical product lifecycle: a literature review (2019)Cost-Effectiveness in Health and Medicine (1996)Comparison of Health State Utility Measures in Patients With Head and Neck Cancer (2015)Advanced therapy medicinal products and health technology assessment principles and practices for value-based and sustainable healthcare (2018)Theory of games and economic behavior (2019)Valuation of SF-6Dv2 Health States in China Using Time Trade-off and Discrete-Choice Experiment with a Duration Dimension (2021)Two Factor Index of Social Position (1957)Methods for the economic evaluation of health care programmes (1987)A power primer. (1992)Mapping from Disease-Specific Measures to Utility: An Analysis of the Relationships between the Inflammatory Bowel Disease Questionnaire and Crohn's Disease Activity Index in Crohn's Disease and Measures of Utility (2007)Lifetime and 12-Month Prevalence of DSM-III-R Psychiatric Disorders in the United States (1994)Usefulness of EQ-5D in assessing health status in primary care patients with major depressive disorder. (2004)Health-Related Quality of Life Measured with EQ-5D in Patients Treated for Depression in Primary Care (2007)Prospect Theory: An Analysis of Decision under Risk (1979)STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT (1986)Prospect theory: An analysis of decision under risk (1988)A comparative review of four preference-weighted measures of health-related quality of life (2003)Comparing preference-based quality-of-life measures: results from rehabilitation patients with musculoskeletal, cardiovascular, or psychosomatic disorders (2008)Discrete Choice Modeling for the Quantification of Health States: The Case of the EQ-5D (2010)Probabilistic Sensitivity Analysis Using Monte Carlo Simulation (1985)Lifetime Benefits and Costs of Intensive Therapy as Practiced in the Diabetes Control and Complications Trial (1996)Cost-effectiveness of Intensive Glycemic Control, Intensified Hypertension Control, and Serum Cholesterol Level Reduction for Type 2 Diabetes (2002)Cost-Effectiveness of Screening for Pre-Diabetes Among Overweight and Obese U.S. Adults (2007)Screening Adults for Pre-Diabetes and Diabetes May Be Cost-Saving (2010)Cost-effectiveness of Interventions to Manage Diabetes: Has the Evidence Changed Since 2008? (2020)Theory of Games and Economic Behavior (1947)Estimation of Patient Preference-Based Utility Weights from the Functional Assessment of Cancer Therapy—General (2007)Measuring Health Preferences for Use in Cost-Utility and Cost-Benefit Analyses of Interventions in Children (2007)Quantifying the Utility of Taking Pills for Cardiovascular Prevention (2015)Belief, Attitude, Intention and Behavior: An Introduction to Theory and Research (1975)Self-efficacy: Toward a unifying theory of behavioral change. (1977)Self-efficacy: Toward a unifying theory of behavioral change. (1977)Assessing cost-effectiveness in healthcare: history of the $50,000 per QALY threshold (2008)What Does the Value of Modern Medicine Say About the $50,000 per Quality-Adjusted Life-Year Decision Rule? (2008)Cost effectiveness of strategies to combat cardiovascular disease, diabetes, and tobacco use in sub-Saharan Africa and South East Asia: mathematical modelling study (2012)Cost-effectiveness of screening for chronic kidney disease in the general adult population: a systematic review (2023)Population-Wide Screening for Chronic Kidney Disease (2023)Measurement of health state utilities for economic appraisal (1986)Utility approach to measuring health-related quality of life (1987)The value of risks to life and health (1993)Background Risks and the Value of a Statistical Life (2001)QALYs Versus WTP (2002)Approaches to Estimating the Health State Dependence of the Utility Function (2009)
this work references cited by second hop

References

No references inside the corpus for this window.

Cited by

  • 2000Valuing Health-Related Quality of Life222 cited
  • 1999A Review of the Use of Health Status Measures in Economic Evaluation194 cited
  • 1998Patient-assigned health state utilities for depression-related outcomes: differences by depression severity and antidepressant medications182 cited
  • 2004Screening for Type 2 Diabetes Mellitus: A Cost-Effectiveness Analysis178 cited
  • 2001Assessing Values for Health: Numeracy Matters175 cited
  • 1998Alternative approaches to valuing intangible health losses: the evidence for multiple sclerosis164 cited
  • 2002Utilities Measured by Rating Scale, Time Trade-off, and Standard Gamble: Review and Reference for Health Care Professionals.140 cited
  • 1997An evaluation of utility measurement in Crohn's disease140 cited
  • 2010A Health Policy Model of CKD: 2. The Cost-Effectiveness of Microalbuminuria Screening135 cited
  • 1997EUR-ASSESS Project Subgroup Report on Dissemination and Impact127 cited
  • 2000Parents' utilities for outcomes of occult bacteremia.124 cited
  • 1996Health status and hypertension: A population-based study124 cited
  • 1997Convergent and Discriminant Validity of a Generic and a Disease-Specific Instrument to Measure Quality of Life in Patients with Skin Disease121 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

2003
Patient and Community Preferences for Outcomes in Prostate Cancer
119 cited
  • 2003The cost effectiveness of rofecoxib and celecoxib in patients with osteoarthritis or rheumatoid arthritis114 cited
  • 2015Economic Evaluation of a Pharmaceutical Care Program for Elderly Diabetic and Hypertensive Patients in Primary Health Care: A 36-Month Randomized Controlled Clinical Trial110 cited